Pappagallo, G.L., and M. Rizzo. “Directness and Quality of Evidence of Bevacizumab Combined With Chemotherapy for Platinum-Resistant, Recurrent Ovarian Cancer in the AURELIA Trial:  ”. Cancer Breaking News 2, no. 2 (October 15, 2014): 39–41. Accessed November 23, 2024. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/274.